Skip to content

A study about the use of whole body cooling for severe respiratory distress due to meconium aspiration syndrome (MAS) in neonates

Whole body hypothermia and meconium aspiration syndrome: international multicentre retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN10541833
Enrollment
Unknown
Registered
2015-11-24
Start date
2006-01-01
Completion date
Unknown
Last updated
2016-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meconium aspiration syndrome Neonatal Diseases Neonatal aspiration of meconium

Interventions

The intervention being tested is whole body hypothermia. There are interesting animal and translational data suggesting the usefulness of whole body hypothermia for some forms of respiratory failure a

Sponsors

Individual sponsor (Italy)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Study cohort consisted of MAS neonates treated with WBH according to the TOBY trial criteria (see above). Control cohort consisted of MAS babies in whom TOBY criteria were not met and WBH was not instigated. All babies had to fulfill the following MAS diagnostic criteria: 1. Meconium-stained amniotic fluid 2. Need for intubation and tracheal suctioning in the delivery room according to the American Academy of Pediatrics neonatal resuscitation guidelines 3. Typical chest radiograph appearance 4. Oxygenation index (OI) > 10 at the intensive care unit admission

Exclusion criteria

Exclusion criteria: 1. Major congenital malformation or known chromosomal abnormalities 2. Any lung disease other than MAS 3. Need for extra-corporeal membrane oxygenation (ECMO)

Design outcomes

Primary

MeasureTime frame
Gas exchange over the first 72 hours of life (as described by oxygenation index, PaCO2 and pH)

Secondary

MeasureTime frame
1. Duration of invasive mechanical ventilation 2. Total duration of respiratory support (defined as the total time spent under invasive, non-invasive ventilation, continuous positive airway pressure/high flow nasal cannulae and free oxygen therapy) 3. Length of stay in the intensive care unit 4. Length of hospital stay

Countries

Australia, Brazil, France, Italy, Netherlands, Spain, United Kingdom, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026